Trastorno Bipolar
El cannabis ha llamado la atención como una posible terapia complementaria para el trastorno bipolar, ofreciendo beneficios terapéuticos cuando se utiliza de manera prudente. Los estudios sugieren que el cannabis puede aliviar síntomas como los cambios de humor, la ansiedad y los trastornos del sueño comúnmente asociados con el trastorno bipolar (Gruber et al., 2020). El cannabidiol (CBD), un componente no psicoactivo del cannabis, ha demostrado ejercer efectos ansiolíticos y estabilizadores del estado de ánimo, lo que puede complementar los tratamientos farmacológicos tradicionales (Blessing et al., 2015). Además, los pacientes han reportado una mejora en la calidad del sueño, un factor crítico en el manejo del trastorno bipolar, tras el uso de cannabis (Babson et al., 2017).
Si bien el compuesto psicoactivo tetrahidrocannabinol (THC) requiere una administración cuidadosa debido a su potencial para exacerbar los síntomas maníacos, sus propiedades ansiolíticas pueden ser beneficiosas para algunos pacientes durante las fases depresivas (Turna et al., 2019). Asimismo, el cannabis puede reducir la dependencia de múltiples medicamentos, promoviendo una mayor adherencia del paciente y una mejor calidad de vida en general (Corroon & Phillips, 2018). Sin embargo, es fundamental utilizar el cannabis bajo supervisión médica para garantizar una dosificación óptima y evitar efectos adversos. Se necesita investigación continua para comprender plenamente su papel en el tratamiento de esta condición compleja.
References
- 1. Babson, K. A., Sottile, J., & Morabito, D. (2017). Cannabis, cannabinoids, and sleep: a review of the literature. Current Psychiatry Reports, 19(4), 23.
- 2. Blessing, E. M., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015). Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics, 12(4), 825-836.
- 3. Corroon, J. M., & Phillips, J. A. (2018). A cross-sectional study of cannabidiol users. Cannabis and Cannabinoid Research, 3(1), 152-161.
- 4. Gruber, S. A., Rogowska, J., & Yurgelun-Todd, D. A. (2020). Neurocognition in adult bipolar disorder and cannabis use. Brain Imaging and Behavior, 14(2), 487-497.
- 5. Turna, J., Patterson, B., & Van Ameringen, M. (2019). Is cannabis treatment for anxiety, mood, and related disorders ready for prime time? Depression and Anxiety, 36(11), 1003-1019.
Servicios relacionados
Cannabis has emerged as a complementary option in managing cancer-related symptoms, providing…
Cannabis has shown promise as a therapeutic option for managing Crohn’s disease, a chronic…
Cannabis has gained recognition as a potential therapy for managing chronic pain, offering relief…
Cannabis is being explored as a potential adjunct therapy for managing depression, offering…
Cannabis, particularly cannabidiol (CBD) has shown significant promise in managing epilepsy,…
Cannabis has been explored as a potential treatment for glaucoma, a condition characterized…
Cannabis is being studied as a potential therapy for managing pain associated with gout, a form of…
Cannabis is being explored as a complementary therapy for managing symptoms associated with….
Cannabis has demonstrated potential in improving the quality of life for individuals living with..
Cannabis has been studied for its potential to help manage hypertension (high blood pressure), a…
Cannabis has gained as a potential treatment for Irritable Bowel Syndrome (IBS), a gastrointestinal disorder…
Cannabis has gained attention as a potential treatment for insomnia, a common sleep disorder..
Cannabis has shown potential in the treatment of migraines, a neurological condition characterized…
Cannabis has shown potential as a therapeutic option for managing symptons of multiple sclerosis (MS), a chronic…